Priority Admission Application Deadlines: https://www.grad.usf.edu/majors
Drug Discovery, Delivery, Development & Manufacturing
Also offered as a Concurrent Degree
Contact Information: https://www.grad.usf.edu/majors
The Master’s of Science (M.S.) in Pharmaceutical Nanotechnology is designed to train students in the skills they will need to understand the burgeoning technological advances in science at the nanoscale and how new nanomaterials and processes can be applied to drug delivery, diagnosis, treatment monitoring, tissue regeneration, personalized medicine and more. This major aims to bridge the gap between nanotechnology and medicine, providing students with advanced knowledge, skills and practical experience within the principles, technology and applications within this exciting and innovative area.
Major Research Areas:
Nano, Nanotechnology, Nano Pharmacy, Nano Pharmaceutics, Nano Pharmaceutical
Must meet University Admission and English Proficiency requirements, as well as requirements for admission to the major, listed below.
- Bachelor’s degree preferably in the biomedical, biological, chemical sciences or engineering
- GRE, MCAT, PCAT, or DAT standardized test scores. May be waived if the overall undergraduate GPA is 3.80 or higher.
- Minimum of two (2) letters of recommendation (preferably from previous professors or employers within the field of science; – all must be fairly recent – within the last five years of coursework or employment).
- A resume
- Professional Statement
- Interview (Optional, at program’s discretion)
- A course-by-course evaluation from a foreign transcript evaluation
- Final determination for admission will be made by Graduate Director based on GPA, GRE, MCAT, PCAT or DAT scores, letters of recommendations, resume and personal statement combined.
Total Minimum Hours – 32 credit hours
- Core Requirements - 11 credit hours
- Concentration/Track – 13 credit hours minimum
- Capstone (3 hours) or Thesis (8 hours)
Core Requirements (11 Credit Hours)
Students select from the following Tracks or Concentrations:
General Track (18 Credit Hours)
- Electives 18
- Plus the Capstone requirement
Entrepreneurship Track (18 Credit Hours)
The one-semester internship in a matched industry, institute or center must be approved by the Associate Dean of Graduate Programs. The Internship will culminate in a final project, which will be presented at the end of the Capstone course. Students must receive an evaluation of Satisfactory or higher from their internship supervisor to successfully complete the Internship course.
Research Track (13 Credit Hours)
- Electives - 13
- Plus the thesis requirement
Biomedical Engineering Concentration (18 Credit Hours)
Drug Discovery, Delivery, Development & Manufacturing Concentration (13 Credit Hours)
Capstone (3 Credit Hours)
As part of the Capstone course, students will also submit and present an e-portfolio outlining their understanding of Pharmaceutical Nanotechnology as a whole with artifacts from previous courses that demonstrate their learning throughout the program. Students must successfully complete PHA 6533, including submission and presentation of e-Portfolio.
Thesis (8 Credit Hours Minimum)
Students will conduct original research in a lab approved by the Associate Dean of Graduate Programs and submit a final Committee-Approved Thesis, including oral defense, following guidelines from the Office of Graduate Studies. Students must submit a final Committee-Approved Thesis, including oral defense, following ETD guidelines from the Office of Graduate Studies (http://www.grad.usf.edu/ETD-res-main.php).
- PHA 6971 Master’s Thesis Credit Hours: 1 (8 credits for this program) (to be taken over the final three semesters in a 3-3-2 credit hour sequence unless otherwise approved by the Program Director)
For non-thesis students, successful completion and presentation of the e-Portfolio in the Capstone course will be used in lieu of a comprehensive exam. For thesis students, the final Committee-Approved thesis, including defense, will be used in lieu of a comprehensive exam.